PHASE 1 AND 2 TRIALS OF COMBINATION THERAPY WITH GEMCITABINE AND CANDESARTAN IN ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Nakai, Y. [1 ]
Isayama, H. [1 ]
Ijichi, H. [1 ]
Sasaki, T. [1 ]
Ito, Y. [2 ]
Matsubara, S. [3 ]
Yagioka, H. [4 ]
Nagano, R. [5 ]
Kawakubo, K. [1 ]
Kogure, H. [1 ]
Yamamoto, N. [1 ]
Sasahira, N. [1 ]
Hirano, K. [1 ]
Tada, M. [1 ]
Koike, K. [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138654, Japan
[2] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan
[3] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan
[5] Kanto Cent Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [22] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Nakai, Y.
    Isayama, H.
    Sasaki, T.
    Sasahira, N.
    Tsujino, T.
    Toda, N.
    Kogure, H.
    Matsubara, S.
    Ito, Y.
    Togawa, O.
    Arizumi, T.
    Hirano, K.
    Tada, M.
    Omata, M.
    Koike, K.
    BRITISH JOURNAL OF CANCER, 2012, 106 (12) : 1934 - 1939
  • [23] A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
    Y Nakai
    H Isayama
    T Sasaki
    N Sasahira
    T Tsujino
    N Toda
    H Kogure
    S Matsubara
    Y Ito
    O Togawa
    T Arizumi
    K Hirano
    M Tada
    M Omata
    K Koike
    British Journal of Cancer, 2012, 106 : 1934 - 1939
  • [24] Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials
    Ciliberto, Domenico
    Botta, Cirino
    Correale, Pierpaolo
    Rossi, Marco
    Caraglia, Michele
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (03) : 593 - 603
  • [25] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Shui-Fang Jin
    Zhao-Kun Fan
    Lei Pan
    Li-Ming Jin
    Hepatobiliary & Pancreatic Diseases International, 2017, 16 (03) : 236 - 244
  • [26] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Jin, Shui-Fang
    Fan, Zhao-Kun
    Pan, Lei
    Jin, Li-Ming
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (03) : 236 - 244
  • [27] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Mahipal, Amit
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Goyal, Gaurav
    Soares, Heloisa
    Neuger, Anthony
    Copolla, Domenico
    Kim, Jongphil
    Kim, Richard
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 473 - 481
  • [28] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Amit Mahipal
    Sri Harsha Tella
    Anuhya Kommalapati
    Gaurav Goyal
    Heloisa Soares
    Anthony Neuger
    Domenico Copolla
    Jongphil Kim
    Richard Kim
    Investigational New Drugs, 2019, 37 : 473 - 481
  • [29] A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Ishiguro, Y
    Morizane, C
    Matsubara, J
    Furuse, J
    Ishii, H
    Nagase, M
    Nakachi, K
    ONCOLOGY, 2005, 69 (05) : 421 - 427
  • [30] Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials
    Ottaiano, Alessandro
    Capozzi, Monica
    De Divitiis, Chiara
    De Stefano, Alfonso
    Botti, Gerardo
    Avallone, Antonio
    Tafuto, Salvatore
    ACTA ONCOLOGICA, 2017, 56 (03) : 377 - 383
12345